Literature DB >> 22309045

Rapid-onset heparin-induced thrombocytopenia without previous heparin exposure.

Zsolt Olah1, Adrienne Kerenyi, Janos Kappelmayer, Agota Schlammadinger, Katalin Razso, Zoltan Boda.   

Abstract

Heparin-induced thrombocytopenia (HIT) is one of the most common immune-mediated drug reactions. Immunoglobulin G-type antibodies against platelet factor 4(PF4)/heparin complexes are known to play a key role in the pathogenesis of HIT. Rapid-onset HIT is caused by the presence of circulating HIT antibodies at the time of heparin readministration. These antibodies are generally resulted from a recent immunizing exposure to heparin. Here we report a case of rapid-onset HIT developed after a septicemia without previous heparin exposure. The diagnosis of HIT as well as the presence of platelet activating and heparin-dependent antibodies was confirmed by ELISA and flow cytometric functional assays. Our case report reinforces that rapid-onset HIT cannot be excluded only based on the absence of previous heparin exposure. In addition, it may support the new theory of pre-immunization by PF4-coated bacteria in the pathomechanism of HIT. We also call the attention that venous limb gangrene can be rarely associated with HIT and thrombosis even in the absence of coumarin therapy. Furthermore, transient presence of anti-phospholipid antibodies can cause a differential diagnostic problem in the cases of HIT.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22309045     DOI: 10.3109/09537104.2011.650245

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  4 in total

1.  A case of severe COVID-19 with pulmonary thromboembolism related to heparin-induced thrombocytopenia during prophylactic anticoagulation therapy.

Authors:  Kosaku Sasaki; Masayuki Murata; Keiji Nakamura; Yuji Matsumoto; Yuko Nakashima; Sho Yamasaki; Azusa Ota; Satoshi Hiramine; Koji Takayama; Hiroaki Ikezaki; Kazuhiro Toyoda; Eiichi Ogawa; Nobuyuki Shimono
Journal:  J Infect Chemother       Date:  2022-05-11       Impact factor: 2.065

2.  Profiling Heparin-Induced Thrombocytopenia (HIT) Antibodies in Hospitalized Patients With and Without Diabetes.

Authors:  Margaret Prechel; Susan Hudec; Elizabeth Lowden; Vicki Escalante; Nicholas Emanuele; Maryann Emanuele; Jeanine M Walenga
Journal:  Clin Appl Thromb Hemost       Date:  2018-11-12       Impact factor: 2.389

3.  Emphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia.

Authors:  M Margaret Prechel; Jeanine M Walenga
Journal:  Thromb J       Date:  2013-04-05

4.  Flow Cytometric Investigation of Classical and Alternative Platelet Activation Markers.

Authors:  Béla Nagy; Ildikó Beke Debreceni; János Kappelmayer
Journal:  EJIFCC       Date:  2013-01-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.